Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00026239
DRKS00026239
Recruiting
Not Applicable

Evaluation of whole-body MRI in diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors compared with the gold standard SSR-PET/CT - NET_MET

Klinikum der Universität München, Campus Großhadern0 sites20 target enrollmentFebruary 3, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsD48Neoplasm of uncertain or unknown behaviour of other and unspecified sites

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
D48
Sponsor
Klinikum der Universität München, Campus Großhadern
Enrollment
20
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum der Universität München, Campus Großhadern

Eligibility Criteria

Inclusion Criteria

  • •Clinically indicated MRI examination,
  • •Existing clinical indication for liver MRI,
  • •Patient's legal capacity, available written documentation of the informed consent interview and patient's consent to participate in the study,
  • •Additional SSTR\- PET\-CT at the same time points (maximum 3 months time difference).

Exclusion Criteria

  • •Impaired renal function (GFR \< 30 ml/min/1\.73m²),
  • •Known intolerance of gadolinium\-containing contrast agent,
  • •Clinically or hemodynamically unstable patients,
  • •Other contraindications to MRI examination (claustrophobia, pacemakers or other implants not compatible with 3T MRI, metal shards, etc.),
  • •Pregnant women and nursing mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body ScannerMultiple MyelomaBone Metastases
NCT05381077Cliniques universitaires Saint-Luc- Université Catholique de Louvain30
Active, not recruiting
Not Applicable
To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancy
EUCTR2004-002053-31-GBHammersmith Hospital100
Completed
Not Applicable
MRI assessment and patient specific biomechanical modelling of ACL deficient knees to improve ACL reconstructive surgery; a feasibility study.
NL-OMON42444Academisch Medisch Centrum8
Unknown
Not Applicable
Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative StagingRectal Cancer
NCT01745874University of Lausanne Hospitals20
Unknown
Not Applicable
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniquesProstate Cancer
NCT02935816University College, London130